The stock prices of most publicly-traded nuclear companies that have received a loan, contract, or financial incentive from Donald Trump’s administration have declined since receiving that favor.

Trump’s administration has handed the nuclear industry tens of billions of dollars of incentives in the past year, including a new $4.2 billion federal loan to Ohio nuclear plant operator Vistra announced today.

Another $80 billion proposal between Cameco and Brookfield Asset Management would have handed the US government 20% of future profits or equity in the public-private partnership.

Despite a 22% boost in its stock price when that deal was announced in October, its shares are 12% lower today than the date of that deal. Brookfield Asset Management, the second party to that deal, has lost 15% YTD, and has performed even worse when measured from the October announcement date.

On October 29, Nuclear power company NuScale said its private partner ENTRA1 Energy stands to receive up to $25 billion of US-Japanese investment under Trump’s international trade deal. Politico described ENTRA1 as a three-year-old startup with a skeleton staff.

In November 2025, publicly-traded Constellation Energy secured a $1 billion loan to restart its Crane nuclear plant in Pennsylvania.

In December 2025, Holtec, which owns a nuclear plant in Michigan, received a $400 million award from the Energy Department after drawing at least six disbursements from a $1.52 billion guarantee that the Biden administration finalized.

On January 6, 2026, Centrus Energy won a $900 million uranium enrichment task order from the US Energy Department.

Source link